Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 15 of 15 results for selenium

  1. SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea (DG44)

    Evidence-based recommendations on SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea

    Diagnostics guidance
    Published
    17 November 2021
    View recommendations

    Sections for DG44

  2. Further data collection and research are recommended to understand how SeHCAT (tauroselcholic [75 selenium] acid) test results affect clinical decision making.

    and research are recommended to understand how SeHCAT (tauroselcholic [75 selenium] acid) test results affect clinical decision making....

    Research recommendation
    Published
    16 December 2021

  3. What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism?

    NG145/11 Question What is the clinical and cost effectiveness of selenium for people with subclinical hypothyroidism? Any explanatory...

    Research recommendation
    Published
    10 February 2020

  4. Thyroid disease: assessment and management (NG145)

    This guideline covers investigating all suspected thyroid disease and managing primary thyroid disease (related to the thyroid rather than the pituitary gland). It does not cover managing thyroid cancer or thyroid disease in pregnancy. It aims to improve quality of life by making recommendations on diagnosis, treatment, long-term care and support.

    NICE guideline
    Last updated
    12 October 2023
    View recommendations

    Sections for NG145

  5. Further data collection and research are recommended to assess the effectiveness of treatment options for bile acid diarrhoea. Consideration should be given to how well the treatments are tolerated and how they affect the severity of symptoms in the longer term.

    guidance details Comes from guidance SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea Number DG44 Date

    Research recommendation
    Published
    16 December 2021

  6. Further data collection and research are recommended to better understand the health-related quality of life in people with bile acid diarrhoea. Consideration should be given to how quality of life differs before and after a positive or negative test and diagnosis, and how it is affected by treatment and symptom severity.

    guidance details Comes from guidance SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea Number DG44 Date

    Research recommendation
    Published
    16 December 2021

  7. Further data collection and research are recommended to assess clinical outcomes after positive and negative SeHCAT test results. This research should focus on clinical outcomes relevant to people with chronic diarrhoea, such as severity of symptoms, including urgency. Clinical outcomes should be measured in the short and long term.

    guidance details Comes from guidance SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea Number DG44 Date

    Research recommendation
    Published
    16 December 2021

  8. Research is needed to establish the efficacy and tolerability of bile acid sequestrants among people with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

    guidance details Comes from guidance SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid...

    Research recommendation
    Published
    9 June 2015

  9. Research is needed to establish the nature of bile acid malabsorption and whether bile acid malabsorption is a primary or secondary condition in people diagnosed with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

    guidance details Comes from guidance SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid...

    Research recommendation
    Published
    9 June 2015

  10. Research is needed to establish the validity and accuracy of the SeHCAT (tauroselcholic [75selenium] acid) test and of any potential alternative technologies for measuring bile acid malabsorption in people with chronic diarrhoea diagnosed with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

    guidance details Comes from guidance SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid...

    Research recommendation
    Published
    9 June 2015

  11. What is the clinical and cost effectiveness of levothyroxine (T4) and liothyronine (T3) combination therapy compared with T4 alone for people with hypothyroidism whose symptoms have not responded sufficiently to T4 alone? Does DiO2 polymorphism affect the response to combination therapy with T4 and T3?

    over 65.The committee were unable to make recommendations on iodine or selenium supplements because of a lack of evidence. How the...

    Research recommendation
    Published
    10 February 2020

  12. Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32)

    This guideline covers identifying and caring for adults who are malnourished or at risk of malnutrition in hospital or in their own home or a care home. It offers advice on how oral, enteral tube feeding and parenteral nutrition support should be started, administered and stopped. It aims to support healthcare professionals identify malnourished people and help them to choose the most appropriate form of support.

    Clinical guideline
    Last updated
    4 August 2017
    View recommendations

    Sections for CG32

  13. Eltrombopag for treating chronic immune thrombocytopenia (TA293)

    Evidence-based recommendations on eltrombopag (Revolade) for treating chronic immune thrombocytopenia in adults.

    Technology appraisal guidance
    Last updated
    26 October 2018
    View recommendations

    Sections for TA293

  14. SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection (DG7)

    This guidance has been updated and replaced by NICE diagnostics guidance 44.  

    Diagnostics guidance
    Published
    28 November 2012

  15. Research recommendations

    and research are recommended to understand how SeHCAT (tauroselcholic [75 selenium] acid) test results affect clinical decision making.